Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer.

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer. Clin Cancer Res. 2014 Jun 15; 20(12):3280-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.